3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Low-grade Glioma
1
Glioma
1
Diffuse Intrinsic Pontine Glioma
1
Craniopharyngioma
1
Brain Neoplasms
1
Interventions
Surgical Procedures, Operative
3
Exenatide
3
tocilizumab
2
Surveys and Questionnaires
2
Radiotherapy
2
Proton Therapy
2
Mental Status and Dementia Tests
2
Magnetic Resonance Spectroscopy
2
Donepezil
2
trametinib
1
tozuleristide
1
tovorafenib
1
temsirolimus
1
gallium Ga 68 dotatate
1
dabrafenib
1
cobimetinib
1
binimetinib
1
antineoplaston AS 2-1
1
antineoplaston A10
1
anlotinib
1
Vemurafenib
1
Tumor Burden
1
Transurethral Resection of Bladder
1
Thalidomide
1
Temozolomide
1
Radiotherapy, Image-Guided
1
Radiation
1
Qsymia
1
Prednisone
1
Photochemotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Craniopharyngioma
×
tovorafenib
×
Clear all
NCT05465174
2026-04-23
PNOC029
University of California, San Francisco
Phase 2
Recruiting
57 enrolled